- Home
- AGEN vs BSBK Comparison
AGEN vs BSBK Comparison
Compare AGEN & BSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- BSBK
- Stock Information
- Founded
- AGEN 1994
- BSBK 1893
- Country
- AGEN United States
- BSBK United States
- Employees
- AGEN N/A
- BSBK N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- BSBK Banks
- Sector
- AGEN Health Care
- BSBK Finance
- Exchange
- AGEN Nasdaq
- BSBK Nasdaq
- Market Cap
- AGEN 87.7M
- BSBK 91.1M
- IPO Year
- AGEN 2000
- BSBK N/A
- Fundamental
- Price
- AGEN $4.70
- BSBK $8.01
- Analyst Decision
- AGEN Buy
- BSBK
- Analyst Count
- AGEN 4
- BSBK 0
- Target Price
- AGEN $13.00
- BSBK N/A
- AVG Volume (30 Days)
- AGEN 1.7M
- BSBK 4.3K
- Earning Date
- AGEN 08-07-2025
- BSBK 07-30-2025
- Dividend Yield
- AGEN N/A
- BSBK N/A
- EPS Growth
- AGEN N/A
- BSBK N/A
- EPS
- AGEN N/A
- BSBK N/A
- Revenue
- AGEN $99,524,000.00
- BSBK $13,694,909.00
- Revenue This Year
- AGEN $12.69
- BSBK N/A
- Revenue Next Year
- AGEN N/A
- BSBK N/A
- P/E Ratio
- AGEN N/A
- BSBK N/A
- Revenue Growth
- AGEN N/A
- BSBK N/A
- 52 Week Low
- AGEN $1.38
- BSBK $6.49
- 52 Week High
- AGEN $18.74
- BSBK $8.66
- Technical
- Relative Strength Index (RSI)
- AGEN 49.92
- BSBK 60.02
- Support Level
- AGEN $4.71
- BSBK $7.79
- Resistance Level
- AGEN $5.22
- BSBK $8.12
- Average True Range (ATR)
- AGEN 0.36
- BSBK 0.34
- MACD
- AGEN -0.12
- BSBK 0.03
- Stochastic Oscillator
- AGEN 14.76
- BSBK 80.90
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.